Le LÚzard
Classified in: Health
Subjects: PER, MAT, SHM

TerrAscend Announces Results of Annual General Meeting


TORONTO, June 29, 2022 /CNW/ - TerrAscend Corp. ("TerrAscend" or the "Company") (CSE:TER) (OTCQX: TRSSF), a leading North American cannabis operator, today announced the results of its annual meeting of shareholders held on June 27, 2022 (the "Meeting"). At the Meeting, the nominees set forth in the Company's management information circular dated April 28, 2022, Mr. Craig Collard, Ms. Lisa Swartzman, Mr. Ed Schutter, Ms. Kara DioGuardi and Mr. Jason Wild, were elected as directors of the Company. In addition, shareholders approved the re-appointment of MNP LLP as the auditor of the Company and the authorization of the Company's board of directors to fix the auditor's remuneration.

The Canadian Securities Exchange ("CSE") has neither approved nor disapproved the contents of this news release. Neither the CSE nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

About TerrAscend
TerrAscend is the leading North American cannabis operator with vertically integrated operations ináPennsylvania,áNew Jersey,áMichiganáandáCalifornia, licensed cultivation and processing operations ináMarylandáand licensed production ináCanada. TerrAscend operates The Apothecarium and Gage dispensary retail locations as well as scaled cultivation, processing, and manufacturing facilities in its core markets. TerrAscend's cultivation and manufacturing practices yield consistent, high-quality cannabis, providing industry-leading product selection to both the medical and legal adult-use markets. The Company owns several synergistic businesses and brands, including Gage Cannabis, The Apothecarium, Ilera Healthcare, Kind Tree, Prism, State Flower, Valhalla Confections, and Arise Bioscience Inc. For more information, visitáwww.terrascend.com.

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
This news release contains "forward-looking information" within the meaning of applicable securities laws. Forward-looking information contained in this press release may be identified by the use of words such as, "may", "would", "could", "will", "likely", "expect", "anticipate", "believe, "intend", "plan", "forecast", "project", "estimate", "outlook" and other similar expressions. Forward-looking information is not a guarantee of future performance and is based upon a number of estimates and assumptions of management in light of management's experience and perception of trends, current conditions and expected developments, as well as other factors relevant in the circumstances, including assumptions in respect of current and future market conditions, the current and future regulatory environment, and the availability of licenses, approvals and permits.

Actual results and developments may differ materially from those contemplated by these statements. Such forward-looking statements are based on certain assumptions regarding expected growth, results of operations, performance, industry trends and growth opportunities. These assumptions may prove to be incorrect. Readers are cautioned not to place undue reliance on forward-looking statements.

Forward-looking information is subject to a variety of risks and uncertainties that could cause actual events or results to differ materially from those projected in the forward-looking information. Such risks and uncertainties include, but are not limited to, current and future market conditions; risks related to federal, state, provincial, territorial, local and foreign government laws, rules and regulations, including federal and state laws ináthe United Statesárelating to cannabis operations ináthe United States; and the risk factors described in our Registration Statement on Form 10 and other filings with the U.S. Securities and Exchange Commission, which are available atáwww.sec.gov, and other filings with Canadian securities regulators, including TerrAscend's management information circular datedáOctober 4, 2021, and TerrAscend's most recently filed MD&A, both filed with the Canadian securities regulators and available under TerrAscend's profile on SEDAR atáwww.sedar.com.

The statements in this press release are made as of the date of this release. TerrAscend disclaims any intent or obligation to update any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

Caution Regarding Cannabis Operations in the United States
Investors should note that there are significant legal restrictions and regulations that govern the cannabis industry in the United States. Cannabis remains a Schedule I drug under the US Controlled Substances Act, making it illegal under federal law in the United States to, among other things, cultivate, distribute or possess cannabis in the United States. Financial transactions involving proceeds generated by, or intended to promote, cannabis-related business activities in the United States may form the basis for prosecution under applicable US federal money laundering legislation.

While the approach to enforcement of such laws by the federal government in the United States has trended toward non-enforcement against individuals and businesses that comply with medical or adult-use cannabis programs in states where such programs are legal, strict compliance with state laws with respect to cannabis will neither absolve TerrAscend of liability under U.S. federal law, nor will it provide a defense to any federal proceeding which may be brought against TerrAscend. The enforcement of federal laws in the United States is a significant risk to the business of TerrAscend and any proceedings brought against TerrAscend thereunder may adversely affect TerrAscend's operations and financial performance.

SOURCE TerrAscend


These press releases may also interest you

at 13:25
On the final day of Preventive Medicine 2023 (PM2023), the American College of Preventive Medicine's (ACPM) annual conference, the College announced the winners of the ACPM Board of Regents Scientific Excellence Award for physician, member-led,...

at 13:09
Skin issues can have a serious impact on your health and well-being. For the 7.5 million Americans1 living with psoriasis, itch can be the most bothersome part of their condition because it can make it difficult to sleep and hard to concentrate, as...

at 13:03
The most recent data on the evolution of COVID-19, in the last 24 hours, in QuÚbec show: Due to a situation beyond our control, data on cases is not available today;2ánew deaths, for a total of 18,254ádeaths, i.e.;0ádeaths in the last 24...

at 13:03
BI┬N Beauty, the premier medical spa in Chicago, announced today that its state-of-the-art facility and curated menu of medical-grade aesthetic treatments are now available without a BI┬N wellness club membership. The move comes as part of BI┬N...

at 13:03
Urgent action is needed to combat America's addiction crisis, and the workplace can play a significant role in this fight. Findings from Fors Marsh's 2022 Workplace Recovery Survey reveal that employers can serve as a crucial support system for...

at 13:00
The Autism Community in Action (TACA) shared that the Center for Disease Control and Prevention (CDC) reports, autism prevalence has significantly increased to 1 in 36 U. S. children diagnosed with autism. The CDC introduced the Autism and...



News published on 29 june 2022 at 16:05 and distributed by: